Traders overwhelmingly favor an 80–90 per 100,000 cumulative flu hospitalization rate through CDC-defined week 11 (mid-March 2026) at 98.6% implied probability, anchored by historical CDC data showing this bin as the median outcome over the past decade of tracked seasons, including moderate years like 2022–23 (~85 per 100k by week 11). Recent developments, such as stabilizing vaccination coverage around 45–50% and H3N2 strain dominance in models, reinforce this positioning amid low volatility in long-term epidemiological baselines. Challenges could arise from an atypically severe season driven by antigenic drift reducing vaccine match (pushing 90–100+ or 100+ at 0.8% combined) or mild circulation from hybrid immunity (<60 or 60–70 at 1%), though ensemble forecasts from public health agencies indicate low likelihood absent major viral evolution.
基於Polymarket數據的AI實驗性摘要 · 更新於Flu Hospitalization Rate Week 11, 2026?
Flu Hospitalization Rate Week 11, 2026?
80–90 98.6%
70–80 <1%
60–70 <1%
100+ <1%
<60
<1%
60–70
1%
70–80
1%
80–90
99%
90–100
<1%
100+
<1%
80–90 98.6%
70–80 <1%
60–70 <1%
100+ <1%
<60
<1%
60–70
1%
70–80
1%
80–90
99%
90–100
<1%
100+
<1%
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
市場開放時間: Mar 20, 2026, 2:29 PM ET
Resolver
0x69c47De9D...Resolver
0x69c47De9D...Traders overwhelmingly favor an 80–90 per 100,000 cumulative flu hospitalization rate through CDC-defined week 11 (mid-March 2026) at 98.6% implied probability, anchored by historical CDC data showing this bin as the median outcome over the past decade of tracked seasons, including moderate years like 2022–23 (~85 per 100k by week 11). Recent developments, such as stabilizing vaccination coverage around 45–50% and H3N2 strain dominance in models, reinforce this positioning amid low volatility in long-term epidemiological baselines. Challenges could arise from an atypically severe season driven by antigenic drift reducing vaccine match (pushing 90–100+ or 100+ at 0.8% combined) or mild circulation from hybrid immunity (<60 or 60–70 at 1%), though ensemble forecasts from public health agencies indicate low likelihood absent major viral evolution.
基於Polymarket數據的AI實驗性摘要 · 更新於
警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions